In turn, the Cancer Genome Atlas (TCGA) classification divides endometrial cancer into four types based on the overall mutational burden (including phosphatase and TENsin homolog (PTEN), p53, polymerase epsilon (POLE) mutations, MSI, and histology), which translates into different clinical outcomes [15,32]. Here, TP53 is linked to endometrial cancer.